Related Experiment Video
Updated: Jul 14, 2025

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
Published on: May 15, 2019
Stress-Dose Steroids: A Potential Therapeutic Option for Refractory Hyperkalemia
Pooya Zardoost1, Zeryab Khan2, Rachel Kim2
1Internal Medicine, OhioHealth Doctors Hospital, Columbus, USA.
Refractory hyperkalemia, a life-threatening condition, may indicate adrenal insufficiency. Prompt treatment with intravenous hydrocortisone resolved the patient's hyperkalemia, potentially avoiding hemodialysis.
Area of Science:
- Nephrology
- Endocrinology
Background:
- Refractory hyperkalemia poses a significant life-threatening risk, often necessitating urgent hemodialysis.
- Multifactorial hyperkalemia can arise from conditions like acute kidney injury and adrenal insufficiency.
Observation:
- A patient presented with severe, refractory hyperkalemia due to acute kidney injury and suspected adrenal insufficiency.
- Standard treatments and excretion agents failed to resolve the hyperkalemia, leading to consideration of hemodialysis.
Findings:
- Intravenous hydrocortisone administration led to the resolution of hyperkalemia within 24 hours.
- The patient's condition improved without the need for hemodialysis, suggesting adrenal insufficiency as a key factor.
Implications:
- Clinicians should consider adrenal insufficiency and initiate stress-dose steroids for refractory hyperkalemia, even without other clear indications.
- Early steroid intervention may prevent the need for hemodialysis, reducing patient risk and healthcare costs.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

